Tag Archives: Bispecific Antibodies

Roche Presents Promising Data on Bispecific Antibodies at ASH 2024, Highlighting Advancements in Lymphoma Treatment

(IN BRIEF) Roche presented new data at the ASH 2024 meeting highlighting the effectiveness of its bispecific antibodies, Columvi and Lunsumio, in treating lymphomas. Long-term studies show durable remissions and immune system recovery with fixed-duration therapies, while real-world data emphasize … Read the full press release